Remove 2023 Remove Ethics Remove Networking
article thumbnail

Goodbye 2023, Hello 2024!

Contrarian Sales Techniques

Reflecting on 2023 2023 has been a year like no other. Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations. The Power of Adaptability : If there's one thing 2023 has taught us, it's the importance of adaptability in sales.

Sales 64
article thumbnail

European regulators prepare for AI in pharma

European Pharmaceutical Review

The workplan, which runs until 2028, will help the European medicines regulatory network (EMRN) embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust decision-making to benefit public and animal health.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

As such, RCTs should not be seen as the only benchmark for rare disease therapies as the cohort of eligible patients may be very small and the severity of a condition can mean that is not ethical to give some trial participants a placebo. Available from: [link] Health Technology Assessment Stakeholder Network – list of members.

article thumbnail

CCC Helps Establish Leiden Institute for FAIR and Equitable Science (LIFES) as a Founding Member

Copyright Clearance Center

The interoperability aspect of FAIR data also ensures appropriate semantic mapping of metadata to enhance the discovery, retrieval, usability, and analysis of data for legitimate research questions that meet legal, ethical, and consent requirements. CCC is committed to creating a diverse, equitable and inclusive (DEI) workplace.

Ethics 98
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic.

article thumbnail

New Research Reveals Perceptions of the Role of AI Among Healthcare Stakeholders

Pharma Marketing Network

“Artificial Intelligence” (AI) is certainly experiencing the shiny object spotlight in 2023. From the HCP perspective, the major areas of concern are: Ethics and Legal Responsibility, Data Quality and Accuracy, Job Displacement, Training and Implementation, Impact of Patient Care, Bias and Misuse, and Dependency and Overreliance.

article thumbnail

AI and clinical diagnostics: following the road less travelled

Clarivate

One of the primary barriers is the disagreement in data protection and the lack of compatibility with ethical aspects. However, as AI applications become more sophisticated, there is documented concern regarding ethics and liability (Jones, 2023). The patent was published in July 2023 and the status is pending as of now.